$MRK News Article - Merck's KEYTRUDA (pembrolizum
Post# of 47038
(Total Views: 70)
Posted On: 10/20/2023 2:05:47 PM
$MRK News Article - Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy Showed Statistically Significant Improvement in Pathological Complete Response (pCR) Rate as Neoadjuvant Therapy Versus Chemotherapy in High-Risk, Early-Stage ER+/HER2- Breast Cancer https://marketwirenews.com/news-releases/merc...15399.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼